Cancer experts are hailing the results of a new trial of a pair of drugs which appear able to shrink tumours in the majority of people with advanced melanoma.
Doctors hope the immunotherapy principles used in the trial could one day have an application for a wide range of cancers.
UK correspondent Olly Barratt reports on the skin cancer trial that is exciting researchers.
IN: "945...
OUT: SOC
DUR: 43 seconds